Fibromyalgia in a Patient with Previous Inflammatory Arthritis: A Case Study Emphasizing the Importance of Comprehensive Evaluation

Sandra Deson^*

Department of Biochemistry, Jimma University, Ethiopia

*Corresponding Author:

Sandra Deson
Department of Biochemistry, Jimma University, Ethiopia
E-mail: sandradeson879@yahoo.com

Received: 01-Aug-2024, Manuscript No. fmijcr-24-150789; Editor assigned: 03- Aug-2024, Pre-QC No. fmijcr-24-150789 (PQ); Reviewed: 16-Aug-2024, QC No. fmijcr-24-150789; Revised: 22-Aug- 2024, Manuscript No. fmijcr-24-150789 (R); Published: 29-Aug-2024, DOI: 10.37532/1758-4272.2024.19(8).215-217

Abstract

Fibromyalgia is a chronic pain condition characterized by widespread musculoskeletal pain, fatigue, and cognitive disturbances. This case study examines a 45-year-old female with a history of inflammatory arthritis who presented with new-onset fibromyalgia symptoms. The study emphasizes the need for comprehensive evaluation in patients with prior rheumatic diseases, as overlapping symptoms can complicate diagnosis and management.

Keywords

Fibromyalgia● inflammatory arthritis● Chronic pain● Diagnosis

Introduction

Fibromyalgia affects approximately 2-4% of the population and is often misdiagnosed or overlooked, particularly in patients with a history of inflammatory arthritis. Inflammatory arthritis can share many symptoms with fibromyalgia, including pain, fatigue, and sleep disturbances. This case study highlights the diagnostic challenges and the importance of thorough assessment in patients transitioning from inflammatory arthritis to fibromyalgia [1-3].

Case Presentation

Patient history

A 45-year-old female, previously diagnosed with rheumatoid arthritis (RA) five years prior, presented to the rheumatology clinic with complaints of widespread pain, fatigue, and cognitive difficulties over the past six months. Her RA had been well-controlled on methotrexate and low-dose corticosteroids. The patient reported a significant increase in pain intensity, affecting her ability to perform daily activities [4].

Clinical Examination

On physical examination, the patient exhibited tenderness at multiple tender points consistent with fibromyalgia criteria, including the neck, shoulders, and lower back. The patient also displayed signs of anxiety and depression, which are often comorbid with fibromyalgia.

Diagnostic Workup

The workup included a comprehensive laboratory evaluation to rule out other potential causes of her symptoms. Blood tests showed normal complete blood count, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) levels, suggesting no active inflammatory process. Thyroid function tests, vitamin D levels, and autoimmune panels were also within normal limits [5].

Diagnosis

Based on the clinical presentation and exclusion of other conditions, the patient was diagnosed with fibromyalgia in the context of her previous inflammatory arthritis. The American College of Rheumatology (ACR) criteria for fibromyalgia were applied, confirming the diagnosis.

Discussion

Overlapping Symptoms

Fibromyalgia can often masquerade as a flare-up of inflammatory arthritis, leading to potential misdiagnosis. In this patient, the transition from inflammatory arthritis to fibromyalgia was particularly challenging due to overlapping symptoms. Chronic pain, fatigue, and sleep disturbances are common in both conditions, necessitating a careful and comprehensive evaluation to delineate between them [6].

Importance of Comprehensive Evaluation

This case highlights the critical need for a holistic approach in evaluating patients with a history of inflammatory arthritis who present with new symptoms. A thorough history and physical examination, combined with appropriate laboratory testing, can help differentiate fibromyalgia from disease flares or other rheumatological conditions [7].

Management Strategies

Management of fibromyalgia in the context of previous inflammatory arthritis requires a multifaceted approach. Treatment options include:

Pharmacological Therapy: Medications such as duloxetine or pregabalin have shown efficacy in reducing fibromyalgia symptoms. Adjusting her current medication regimen to include these agents could alleviate her pain and improve her quality of life [8].

Non-Pharmacological Interventions: Cognitive-behavioral therapy (CBT), physical therapy, and exercise programs are essential components of management. Patients often benefit from structured programs that emphasize gradual increases in physical activity and coping strategies for pain management [9].

Patient Education: Educating the patient about fibromyalgia and its management is crucial. Understanding the condition can empower patients, reduce anxiety, and promote adherence to treatment strategies.

Regular Follow-Up: Continuous monitoring of symptoms and treatment response is vital. Adjustments to the management plan may be necessary as the patient's condition evolves [10].

Conclusion

This case study underscores the complexity of diagnosing fibromyalgia in patients with a history of inflammatory arthritis. Comprehensive evaluation, including detailed history-taking and appropriate laboratory investigations, is essential to distinguish fibromyalgia from other rheumatic conditions. An individualized management plan that incorporates both pharmacological and non-pharmacological strategies can significantly enhance the quality of life for patients navigating the challenges of fibromyalgia.

References

1. Pourakbari B, Mamishi S, Mashoori N, Mahboobi N, Ashtiani MH, Afsharpaiman S, et al. (2010) Frequency and antimicrobial susceptibility of Shigella species isolated in children medical center hospital, Tehran, Iran, 2001–2006. Braz J Infect Dis 14: 153–157.

Indexed at, Google Scholar, Crossref

2. Nikfar R, Shamsizadeh A, Darbor M, Khaghani S, Moghaddam M. (2017) A Study of prevalence of Shigella species and antimicrobial resistance patterns in paediatric medical center, Ahvaz, Iran. Iran J Microbiol 9: 277.

Indexed at, Google Scholar

3. Kacmaz B, Unaldi O, Sultan N, Durmaz R (2014) Drug resistance profiles and clonality of sporadic Shigella sonnei isolates in Ankara, Turkey. Braz J Microbiol 45: 845–849.

Indexed at, Google Scholar, Crossref

4. Akcali A, Levent B, Akbaş E, Esen B (2008) Typing of Shigella sonnei strains isolated in some provinces of Turkey using antimicrobial resistance and pulsed field gel electrophoresis methods. Mikrobiyol Bul 42: 563–572.

Indexed at, Google Scholar

5. Jafari F, Hamidian M, Rezadehbashi M, Doyle M, Salmanzadeh-Ahrabi S, et al. (2009) Prevalence and antimicrobial resistance of diarrheagenic Escherichia coli and Shigella species associated with acute diarrhea in Tehran, Iran. Can J Infect Dis Med Microbiol 20: 56–62.

Indexed at, Google Scholar, Crossref

6. Ranjbar R, Behnood V, Memariani H, Najafi A, Moghbeli M, et al. (2016) Molecular characterisation of quinolone-resistant Shigella strains isolated in Tehran, Iran. J Glob Antimicrob Resist 5: 26–30.

Indexed at, Google Scholar, Crossref

7. Zamanlou S, Ahangarzadeh Rezaee M, Aghazadeh M, Ghotaslou R, et al. (2018) Characterization of integrons, extended-spectrum β-lactamases, AmpC cephalosporinase, quinolone resistance, and molecular typing of Shigella spp. Infect Dis 50: 616–624.

Indexed at, Google Scholar, Crossref

8. Varghese S, Aggarwal A (2011) Extended spectrum beta-lactamase production in Shigella isolates-A matter of concern. Indian J Med Microbiol 29: 76.

Indexed at, Google Scholar, Crossref

9. Peirano G, Agersø Y, Aarestrup FM, Dos Prazeres Rodrigues D (2005) Occurrence of integrons and resistance genes among sulphonamide-resistant Shigella spp. from Brazil. J Antimicrob Chemother 55: 301–305.

Indexed at, Google Scholar, Crossref

10. Kang HY, Jeong YS, Oh JY, Tae SH, Choi CH, et al. (2005) Characterization of antimicrobial resistance and class 1 integrons found in Escherichia coli isolates from humans and animals in Korea. J Antimicrob Chemother 55: 639-644.

Indexed at, Google Scholar, Crossref